Photobiomodulation therapy to treat neuropathic oral pain after contagion by COVID-19

Laser treatment of Neuropathic Pain after COVID-19

Authors

  • Fernanda Cruz Gomes São Leopoldo Mandic, Departamento de Odontopediatria, Campinas, SP, Brazil
  • Christian Naurath Instituto Nacional do Câncer, Rio de Janeiro, RJ, Brazil
  • Luciane Hiramatsu Azevedo USP
  • Denise Maria Zezell Instituto de Pesquisas Energéticas e Nucleares, Centro de Lasers e Aplicações, São Paulo, SP, Brazil.

DOI:

https://doi.org/10.4322/bds.2021.e2962

Abstract

Objective: The purpose of this short communication is to show that although photobiomodulation in the
treatment of neurophathic oral pain after COVID-19 contagion could be an option, photobiomodulation is not
a new technique. PBMT was used with different protocols and pain was assessed using VAS (visual analogue
scale - 0 until 10) before and after the consultation. Results: Evolution of VAS during the sessions showed a
decrease in painful symptomatology as treatment was performed. Conclusion: Based on the results obtained in
the present case report, we concluded that PBMT with the parameters used in this clinical case was an effective,
noninvasive and a new option of treatment for neuralgia resulting from COVID-19.
KEYWORDS
Laser; Photobiomodulation therapy; COVID-19; Oral neuralgia.

Downloads

Download data is not yet available.

Downloads

Published

2021-12-17

Issue

Section

Case Report or Clinical Technique

How to Cite

1.
Gomes FC, Naurath C, Hiramatsu Azevedo L, Zezell DM. Photobiomodulation therapy to treat neuropathic oral pain after contagion by COVID-19: Laser treatment of Neuropathic Pain after COVID-19. BDS [Internet]. 2021 Dec. 17 [cited 2026 Aug. 22];24(4 Suppl). Available from: https://ojs.ict.unesp.br/index.php/cob/article/view/2962

Most read articles by the same author(s)